SYSTEMIC LUPUS ERYTHEMATOSUS IN HIV PATIENT: A CASE STUDY

• Autor(a) principal: SORIANO, CLARINE CRISTINA BARROS
• Data de Publicação: 2024
• Outros Autores: BRASIL, DANIELA DA SILVA, CASTRO, MANUELA SILVA DE NEGREIROS, ALMEIDA, YAGO VINICIUS SPATOLA, ESCOSSIO, ELLEN FIGUEIRA, SILVESTRE NETO, THALES, ROTILLI, GRACIELLI KERPEL, MARINHO, DAIANE TEIXEIRA DE SOUSA, SANTOS, JESSICA CARVALHO, RODRIGUEZ, PAULA CRISTINA RIOS, AZEVEDO, ARIMATÉIA PORTELA DE
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1504
• topic: Antirretrovirais, Pacientes Desistentes do Tratamento, Cooperação e Adesão ao Tratamento, Imunossupressão, Infectologia.; Antiretrovirals, Patients Resistant to Treatment, Cooperation and Adequacy of Treatment, Immunosuppression, Infectology

Introduction: The coexistence of Acquired Immunodeficiency Syndrome-AIDS with Lupus Erythematosus-SLE is extremely rare. In addition to clinical manifestations, a series of laboratory results can occur in both cases. Objective: To report a case of a patient immunosuppressed by HIV and with systemic lupos erythematosus. Methodology: This is a collection of existing secondary information on the electronic record of the study participant. Case study: Patient, female, 44 years old, living with HIV for 13 years, having abandoned treatment for about 3 months and co-infected with Systemic Lupus Erythematosus-SLE for 05 years with abandoning treatment for one year. Ao not soon admitting care from the referring hospital informs that for two weeks we have been feeling productive cough, hyperthermia, hemiparesis on the left with permanence of touch sensitivity, significant weight loss, hair remains itchy without hair. For about a week she has been presenting split plaques in the oropharynx associated with odynophagia and generalized asthenia. She has symptoms of kidney failure. Patient did not appear for outpatient consultations because she was bedridden and had no assistance for or transportation to the hospital. After support and hospitalization, the patient was transferred to the infirmary apparently lucid and oriented. In the hours following the same anuric syndrome occurred during the dialysis procedure, it was hemodynamically destabilized. Transferred to ICU. After 47 hours of intensive care, she presents cardiac arrest with clinical signs of death. Conclusion: Better support and guidance for these patients, from the first time they take medication or the first symptoms of aggravation during hospitalization, may be the greatest benefit to drug treatment